[HTML][HTML] Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases
Infectious diseases are a major threat to global health and cause millions of deaths every
year, particularly in developing countries. The emergence of multidrug resistance …
year, particularly in developing countries. The emergence of multidrug resistance …
Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity
RR Razonable - Frontiers in immunology, 2024 - frontiersin.org
While the general population regained a certain level of normalcy with the end of the global
health emergency, the risk of contracting COVID-19 with a severe outcome is still a major …
health emergency, the risk of contracting COVID-19 with a severe outcome is still a major …
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
PM Kinsella, MA Moso, CO Morrissey… - Transplant Infectious …, 2024 - Wiley Online Library
Antiviral agents with activity against severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) have played a critical role in disease management; however, little is known …
CoV‐2) have played a critical role in disease management; however, little is known …
[HTML][HTML] Antiviral and Monoclonal Antibody Combination Therapy in Haematological Patients in the Omicron Era
S Vita, E Giombini, P De Marco, M Rueca… - … of Hematology and …, 2024 - ncbi.nlm.nih.gov
Immunocompromised (IC) patients are at higher risk for persistent and/or severe SARS-CoV-
2 infection caused by different viral variants, with a high casefatality ratio. 1, 2 The first …
2 infection caused by different viral variants, with a high casefatality ratio. 1, 2 The first …